Skip to content

Extracorporeal Therapy on Shoulder and Neck Pain

Effects of Extracorporeal Shock Wave Therapy on Shoulder and Neck Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02617329
Enrollment
40
Registered
2015-11-30
Start date
2014-09-30
Completion date
2015-06-30
Last updated
2015-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Disorders

Keywords

Extracorporeal shock wave therapy (ESWT), Neck Pain

Brief summary

The purpose of this research was to investigate the clinical effects on the ESWT treatment of shoulder and neck pain.

Detailed description

Extracorporeal shock wave therapy (ESWT) has been used to treat various musculoskeletal disorders. The beneficial effects of the ESWT included pain alleviation and improvement in local blood circulation. However, few study exploring the effects of the ESWT for subjects with shoulder and neck pain.

Interventions

The Extracorporeal shock wave therapy (ESWT) was applied on upper trapezius and levator scapulae following parameters 1.5 bar, per intervention 2000 impulse, once a week for three weeks for the experimental group

OTHERcervical flexion

Education have 8 movement home program for flexion, extension, side bending, rotation in neutral position, and rotation in a position of full cervical flexion.

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Non-specific shoulder and neck pain * Ages between 20yr to 45yr * Shoulder and neck syndrome of upper trapezius and levator scapulae more than 3 months * No using medicine such as anodyne and muscle relaxants.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
The change of visual analogue scale (VAS)Baseline, week 3

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026